Edition:
United States

Nektar Therapeutics (NKTR.OQ)

NKTR.OQ on NASDAQ Stock Exchange Global Select Market

89.60USD
23 Feb 2018
Change (% chg)

$1.39 (+1.58%)
Prev Close
$88.21
Open
$88.70
Day's High
$89.90
Day's Low
$87.13
Volume
426,452
Avg. Vol
811,132
52-wk High
$99.02
52-wk Low
$12.51

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.27 December 24 Feb 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 4 4 4 4
(2) OUTPERFORM 4 4 4 5
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.67 1.67 1.67 1.70

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 4 38.72 48.60 28.50 51.35
Quarter Ending Jun-18 4 107.02 246.60 30.50 55.22
Year Ending Dec-18 7 258.17 394.90 126.20 251.27
Earnings (per share)
Quarter Ending Mar-18 5 -0.27 -0.04 -0.40 -0.21
Quarter Ending Jun-18 5 0.02 0.88 -0.40 -0.21
Year Ending Dec-18 7 -0.77 0.22 -1.58 -0.63

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 117.32 152.93 35.61 30.35
Quarter Ending Jun-17 34.23 34.59 0.36 1.05
Quarter Ending Mar-17 26.80 24.73 2.07 7.73
Quarter Ending Dec-16 40.67 37.45 3.22 7.92
Quarter Ending Sep-16 32.89 36.34 3.44 10.47

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 38.72 38.72 33.43 38.67 51.35
Quarter Ending Jun-18 107.02 107.02 103.75 92.05 55.22
Year Ending Dec-18 258.17 229.88 229.88 222.30 251.27

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-18 0 0 1 1
Quarter Ending Jun-18 0 0 1 0
Year Ending Dec-18 1 0 1 0
Earnings